4P-Pharma is a French biotech company specialized in the development of therapeutics addressing unmet medical needs for Human and Animal Health from drug discovery level up to clinical phase I/II. 4P-Pharma detects innovative breakthrough projects in Universities and research centers SATTs and TTOs in order to accelerate their development as novel drug candidates by a de-risking and partnership approach. Since our creation 5 years ago we have reviewed more than 250 projects from different Universities 12 technologies have entered in our laboratories for preliminary value validation and 1 has been validated and is undergoing further development (4P-004).4P-004 is an innovative treatment for Osteoarthritis for which we are planning to perform a clinical Phase I/II in 2020. This molecule has shown analgesic and anti-inflammatory properties as well as beneficial effects on cartilage.We are open to novel opportunities and have recently initiated collaborations with biotech companies specialized in in-silico drug screening in order to bring health products to the patients faster.
1 rue du Professeur Calmette, IBL
59800 LILLE http://www.4p-pharma.com/